Skip to content

Can Genetic Markers Predict Weight Loss After Gastric By-pass Surgery

Can Genetic Changes Predict Weight Loss and Outcome After Bariatric Surgery and Can it Related to Virus Infection and Function of Liver and Adipose Tissue as Well as Lipid and Protein Profiles.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01736384
Enrollment
2000
Registered
2012-11-29
Start date
2009-02-28
Completion date
2020-02-29
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

There is a variability in weight loss after gastric bypass surgery for obesity despite a standardised surgical procedure. This study aims to investigate if genetic markers can predict outcome after gastric by-pass surgery in treatment of obesity. The investigators will also study if adenovirus infection can influence the outcome after surgery. In a subgroup of patients, hormonal changes after gastric by-pass surgery will be assessed. Lipid and protein patterns will be assessed in plasma and tissues. Omental and subcutaneous fat as well as liver biopsies and whole blood are stored in a biobank. The same tissues will be collected from non-obese controls undergoing gallbladder surgery.

Interventions

PROCEDUREGastric bypass or cholecystectomy

Sponsors

Danderyd Hospital
CollaboratorOTHER
Ersta Hospital, Sweden
CollaboratorOTHER
Karolinska University Hospital
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* laparoscopic gastric by-pass with BMI greater than 35

Exclusion criteria

* unable to understand swedish

Design outcomes

Primary

MeasureTime frameDescription
Genetic markersday of surgery and 1 and 2 years after surgeryBlood samples and tissue biopsies taken at the time of surgery and at follow-up.

Secondary

MeasureTime frameDescription
Lipid and protein patterns in plasma and tissuesday of surgery and at 1 and 2 years postoperativelyBlood samples taken and tissue biopsies taken at the time of surgery and at follow-up
Previous viral infectionAt time of surgeryBlood samples taken before surgery
Genexpression and comorbid diseaseAt time of bariatric surgery and 1-2 years postoperativelyGene expression studies in tissue biopsies and whole blood at time of surgery and follow-up

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026